Rachel Dedinsky, PT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 24400 Highpoint Rd Ste 10, Beachwood, OH 44122 Phone: 216-896-0824 Fax: 216-896-0825 |
Mr. Zachary Fink, DPT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 23175 Commerce Park, Beachwood, OH 44122 Phone: 440-449-3400 Fax: 440-449-3402 |
Jennifer Susan Gerckens, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 23333 Harvard Rd, Beachwood, OH 44122 Phone: 216-593-2208 |
Erin M Rucinski, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 24400 Highpoint Rd Ste 10, Beachwood, OH 44122 Phone: 216-896-0824 Fax: 216-896-0825 |
Ms. Susan Alfieri, LPTA Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 27300 Cedar Rd, Beachwood, OH 44122 Phone: 216-595-7345 |
Kimberly R Blangero, DPT Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 24400 Highpoint Rd Ste 10, Beachwood, OH 44122 Phone: 216-896-0824 Fax: 216-896-0825 |
Kelly A Brzozowski, PT Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 24400 Highpoint Rd Ste 10, Beachwood, OH 44122 Phone: 216-896-0824 Fax: 216-896-0825 |
News Archive
GE Healthcare today announced the final results from a phase 3 study of the investigational PET amyloid imaging agent, [18F]flutemetamol in terminally ill patients who had agreed to undergo postmortem brain autopsy.
Doctors at Henry Ford Hospital reached a medical milestone April 3, performing the 25th successful transcatheter valve replacement using a novel way to access the heart.
Critical Diagnostics, a biomarker company focused on cardiovascular diseases, today announced positive results from a multi-center study in ambulatory heart failure patients, which confirmed that a contemporary panel of biomarkers, including ST2, was strongly predictive of risk and significantly improved the likelihood of identifying patients at risk for adverse events, compared to the most commonly used clinical risk score in heart failure, the Seattle Heart Failure Model.
In a new commentary for the journal Science, an associate vice president for research at The University of Texas at Arlington argues that emerging protein-based immunotherapies could lead to highly effective "off-the-shelf" cancer treatments for more patients.
› Verified 8 days ago